Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-09-22 4:05 pm Purchase | 2026-09-15 | 13G | BETTERLIFE PHARMA INC BETRF | RA Capital Management, L.P. | 55,420,000 9.000% | 55,420,000 (New Position) | Filing History |
| 2026-09-21 6:57 pm Sale | 2026-09-17 | 13D | SIONNA THERAPEUTICS INC SION | RA Capital Management, L.P. | 6,476,193 14.300% | -3,595,519 (-35.70%) | Filing History |
| 2026-09-17 4:32 pm Purchase | 2026-09-15 | 13D | TYRA BIOSCIENCES INC TYRA | RA Capital Management, L.P. | 14,130,492 19.900% | 1,863,917 (+15.20%) | Filing History |
| 2026-09-03 5:11 pm Purchase | 2026-08-27 | 13G | JATT III Acquisition Corp JTTT | RA Capital Management, L.P. | 450,000 5.100% | 450,000 (New Position) | Filing History |
| 2026-08-17 5:09 pm Purchase | 2026-08-10 | 13G | LATIGO BIOTHERAPEUTICS INC LTGO | RA Capital Management, L.P. | 5,295,690 8.400% | 5,295,690 (New Position) | Filing History |
| 2026-08-14 6:38 pm Sale | 2026-08-12 | 13G | GH RESH PLC SHS GHRS | RA Capital Management, L.P. | 4,897,182 7.100% | -2,779,515 (-36.21%) | Filing History |
| 2026-08-14 5:14 pm Sale | 2026-08-12 | 13D | SEPTERNA INC SEPN | RA Capital Management, L.P. | 5,525,324 11.800% | -1,470,534 (-21.02%) | Filing History |
| 2026-08-14 4:47 pm Purchase | 2026-06-30 | 13G | TAYSHA GENE THERAPIES INC TSHA | RA Capital Management, L.P. | 32,886,242 9.900% | 5,223,761 (+18.88%) | Filing History |
| 2026-08-14 4:46 pm Purchase | 2026-06-30 | 13G | RANI THERAPEUTICS HLDGS INC CO RANI | RA Capital Management, L.P. | 11,530,414 9.900% | 1,647,937 (+16.68%) | Filing History |
| 2026-08-14 4:45 pm Purchase | 2026-06-30 | 13G | OVID THERAPEUTICS INC OVID | RA Capital Management, L.P. | 19,549,271 9.900% | 6,289,536 (+47.43%) | Filing History |
| 2026-08-14 4:44 pm Purchase | 2026-06-30 | 13G | KARYOPHARM THERAPEUTICS INC CO KPTI | RA Capital Management, L.P. | 2,302,504 9.900% | 223,591 (+10.76%) | Filing History |
| 2026-08-14 4:43 pm Purchase | 2026-06-30 | 13G | GERON CORP GERN | RA Capital Management, L.P. | 66,502,728 9.900% | 2,514,622 (+3.93%) | Filing History |
| 2026-08-14 4:42 pm Sale | 2026-06-30 | 13G | FULCRUM THERAPEUTICS INC FULC | RA Capital Management, L.P. | 0 0.000% | -6,649,973 (Position Closed) | Filing History |
| 2026-08-14 4:42 pm Sale | 2026-06-30 | 13G | EDGEWISE THERAPEUTICS INC EWTX | RA Capital Management, L.P. | 8,392,730 7.800% | -2,035,707 (-19.52%) | Filing History |
| 2026-08-14 4:41 pm Purchase | 2026-06-30 | 13G | CERVOMED INC CRVO | RA Capital Management, L.P. | 1,266,143 8.600% | 239,206 (+23.29%) | Filing History |
| 2026-08-14 4:40 pm Purchase | 2026-06-30 | 13G | C4 THERAPEUTICS INC CCCC | RA Capital Management, L.P. | 11,383,696 9.900% | 1,942,440 (+20.57%) | Filing History |
| 2026-08-14 4:39 pm Purchase | 2026-06-30 | 13G | BIOCRYST PHARMACEUTICALS INC BCRX | RA Capital Management, L.P. | 15,827,186 6.200% | 525,000 (+3.43%) | Filing History |
| 2026-08-14 4:38 pm Purchase | 2026-06-30 | 13G | AVALO THERAPEUTICS INC PAR AVTX | RA Capital Management, L.P. | 3,483,099 6.300% | 1,027,444 (+41.84%) | Filing History |
| 2026-08-14 4:37 pm Sale | 2026-06-30 | 13G | ATRIUM THERAPEUTICS INC RNA | RA Capital Management, L.P. | 0 0.000% | -864,102 (Position Closed) | Filing History |
| 2026-08-14 4:36 pm Sale | 2026-06-30 | 13G | ADICET BIO INC ACET | RA Capital Management, L.P. | 935,486 9.900% | -247,138 (-20.90%) | Filing History |